The Evolution of Hematopoietic Stem Cell Transplantation to Overcome Access Disparities: The Role of NMDP

Abstract

NMDP recognizes that despite advances in hematopoietic stem cell transplantation (HSCT) and other cell therapies, not all patients have equitable access to treatment, and disparities in outcomes remain. This paper explores the recent work of NMDP to accelerate progress and expand access to more patients through transformative clinical research, particularly in the use of mismatched unrelated donors for HSCT.

Keywords

• mismatched unrelated donors
• HLA
• NMDP
• hematopoietic stem cell transplantation (HSCT)
• CIBMTR
• outcomes